WASHINGTON, D.C., May 24, 2007 – LAWFUEL – The Law News Wire – Lawyers with Hogan & Hartson LLP are representing Cytyc Corporation (NASDAQ: CYTC), a leading provider of surgical and diagnostic products targeting women’s health and cancer diagnostics, in its merger agreement with Hologic, Inc. (NASDAQ: HOLX), a leading provider of diagnostic and medical imaging systems for women’s health care. The combined company, which will be called Hologic, will be a $10 billion global leader in women’s health care and one of the largest companies in the world focused exclusively on advanced technology in women’s health.
Under the terms of the merger agreement, valued at approximately $6.2 billion, Cytyc shareholders will receive 0.52 shares of Hologic common stock and $16.50 in cash, or approximately $46.46 per share. The transaction is expected to close in the third quarter of 2007.
The Hogan & Hartson team is being led by Washington, D.C. partners Joseph E. Gilligan, Joseph G. Connolly, Jr., and Amit Saluja and included corporate associates Eun Ah Choi, Kyle McNamara, Megan Wang, James Black, Jason McCaffrey, Christian Ulrich, and Dirk Van Den Bos.
Other members of the Hogan & Hartson team include: Jonathan Kahan, Marc Bozeman, and Michael Heyl (FDA); Liz Dunst, Stuart Langbein, and Ronald Wisor (health regulatory); Bob Leibenluft, Mary Anne Mason, Michele Harrington, Mariabruna Fimognari, and Leigh Oliver (antitrust); Dan Davidson and Andrea Ramezan-Jackson (tax); Bill Neff and Carin Carithers (employee benefits); Scott Reisch, Jennifer McClister, and Seaton Thedinger (environmental); Ben Hammond and Rette Lopp (banking); and Michael Kidney and Steve Kuperberg (litigation).
